Skip to main content
Journal cover image

Polymerase chain reaction adjustment in antimalarial trials: molecular malarkey?

Publication ,  Journal Article
Juliano, JJ; Taylor, SM; Meshnick, SR
Published in: J Infect Dis
July 1, 2009

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Infect Dis

DOI

ISSN

0022-1899

Publication Date

July 1, 2009

Volume

200

Issue

1

Start / End Page

5 / 7

Location

United States

Related Subject Headings

  • Sulfadoxine
  • Randomized Controlled Trials as Topic
  • Pyrimethamine
  • Polymerase Chain Reaction
  • Microbiology
  • Malaria, Falciparum
  • Humans
  • Drug Therapy, Combination
  • Antimalarials
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Juliano, J. J., Taylor, S. M., & Meshnick, S. R. (2009). Polymerase chain reaction adjustment in antimalarial trials: molecular malarkey? J Infect Dis, 200(1), 5–7. https://doi.org/10.1086/599379
Juliano, Jonathan J., Steve M. Taylor, and Steven R. Meshnick. “Polymerase chain reaction adjustment in antimalarial trials: molecular malarkey?J Infect Dis 200, no. 1 (July 1, 2009): 5–7. https://doi.org/10.1086/599379.
Juliano JJ, Taylor SM, Meshnick SR. Polymerase chain reaction adjustment in antimalarial trials: molecular malarkey? J Infect Dis. 2009 Jul 1;200(1):5–7.
Juliano, Jonathan J., et al. “Polymerase chain reaction adjustment in antimalarial trials: molecular malarkey?J Infect Dis, vol. 200, no. 1, July 2009, pp. 5–7. Pubmed, doi:10.1086/599379.
Juliano JJ, Taylor SM, Meshnick SR. Polymerase chain reaction adjustment in antimalarial trials: molecular malarkey? J Infect Dis. 2009 Jul 1;200(1):5–7.
Journal cover image

Published In

J Infect Dis

DOI

ISSN

0022-1899

Publication Date

July 1, 2009

Volume

200

Issue

1

Start / End Page

5 / 7

Location

United States

Related Subject Headings

  • Sulfadoxine
  • Randomized Controlled Trials as Topic
  • Pyrimethamine
  • Polymerase Chain Reaction
  • Microbiology
  • Malaria, Falciparum
  • Humans
  • Drug Therapy, Combination
  • Antimalarials
  • 42 Health sciences